Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Inc | $112.6b | $430.24 | -1.1% | 1.1M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $751.48 | -1.9% | 809.5K |
 INSM | Insmed, Inc. | $33.0b | $135.16 | -6.0% | 2.5M |
 BMRN | BioMarin Pharmaceuticals Inc | $10.5b | $53.16 | -1.5% | 1.1M |
 KRYS | Krystal Biotech, Inc. Common Stock | $7.2b | $272.51 | +1.7% | 264.1K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.2% | 5.3M |
 CRSP | CRISPR Therapeutics AG | $4.3b | $48.79 | -11.6% | 3.9M |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.2b | $27.11 | -10.1% | 4.7M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $2.2b | $20.27 | -0.7% | 2.1M |
 VCEL | Vericel Corporation | $1.6b | $35.61 | +3.5% | 565.7K |
 NTLA | Intellia Therapeutics, Inc | $1.4b | $16.00 | +0.8% | 9.0M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.2b | $6.39 | -0.2% | 1.9M |
 PGEN | Precigen, Inc. Common Stock | $1.2b | $4.13 | +4.2% | 3.5M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $24.51 | -3.4% | 525.9K |
 QURE | uniQure N.V. | $0.9b | $18.06 | +3.0% | 1.0M |
 BLFS | BioLife Solutions Inc. | $0.9b | $21.36 | -1.7% | 362.4K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.29 | -4.5% | 2.7M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $0.7b | $9.22 | -1.1% | 673.4K |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.6b | $12.54 | -1.9% | 413.2K |
 SLDB | Solid Biosciences Inc. Common Stock | $0.6b | $7.90 | -3.9% | 737.0K |
 OCGN | Ocugen, Inc. Common Stock | $0.6b | $1.67 | 0.0% | 6.1M |
 PRME | Prime Medicine, Inc. Common Stock | $0.6b | $3.70 | -3.6% | 1.6M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $2.29 | -2.5% | 5.5M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $458.3m | $9.05 | +1.2% | 1.5M |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $450.6m | $12.64 | -1.3% | 161.0K |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $437.5m | $9.42 | -2.0% | 514.6K |
 ENGN | enGene Holdings Inc. Common Stock | $414.0m | $8.00 | -1.7% | 222.2K |
 RGNX | REGENXBIO Inc. | $401.0m | $8.78 | -2.3% | 757.0K |
 CYRX | CryoPort, Inc. Common Stock | $393.4m | $10.59 | +4.1% | 243.9K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $384.6m | $5.86 | -2.5% | 940.5K |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $374.0m | $3.53 | -4.1% | 1.9M |
 BNTC | Benitec Biopharma Inc. Common Stock | $344.6m | $12.37 | -2.6% | 140.9K |
 IRD | Opus Genetics, Inc. Common Stock | $309.5m | $5.22 | +0.2% | 655.5K |
 NGNE | Neurogene, Inc. Common Stock | $300.6m | $27.03 | +0.3% | 273.1K |
 CABA | Cabaletta Bio, Inc. Common Stock | $275.0m | $2.94 | -3.6% | 2.0M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $241.3m | $5.41 | -2.0% | 928.6K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $230.6m | $3.79 | -6.2% | 583.5K |
 EDIT | Editas Medicine, Inc. Common Stock | $218.3m | $2.90 | -9.5% | 1.5M |
 CRBU | Caribou Biosciences, Inc. Common Stock | $166.2m | $2.13 | -5.8% | 1.9M |
 KRRO | Korro Bio, Inc. Common Stock | $148.3m | $12.84 | -5.5% | 100.2K |
 CBUS | Cibus, Inc. Class A Common Stock | $138.6m | $1.50 | +3.4% | 396.8K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $134.5m | $0.67 | -1.4% | 3.2M |
 DTIL | Precision BioSciences, Inc. Common Stock | $134.0m | $7.06 | -3.4% | 209.9K |
 INO | Inovio Pharmaceuticals, Inc. | $115.4m | $1.14 | 0.0% | 721.5K |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $114.2m | $0.19 | -25.7% | 31.1M |
 GNLX | Genelux Corporation Common Stock | $103.1m | $2.54 | +0.6% | 129.5K |
 MXCT | MaxCyte, Inc. Common Stock | $72.3m | $0.86 | -0.1% | 343.1K |
 TIL | Instil Bio, Inc. Common Stock | $54.1m | $8.05 | -1.6% | 23.7K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $53.5m | $1.25 | +4.2% | 1.1M |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $47.6m | $1.50 | +4.9% | 136.8K |